
Sign up to save your podcasts
Or


Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.
By ABC4.4
105105 ratings
Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.

98 Listeners

64 Listeners

86 Listeners

32 Listeners

1,734 Listeners

829 Listeners

194 Listeners

765 Listeners

137 Listeners

65 Listeners

65 Listeners

45 Listeners

56 Listeners

160 Listeners

321 Listeners

791 Listeners

149 Listeners

201 Listeners

115 Listeners

242 Listeners

1,008 Listeners

46 Listeners

5 Listeners

115 Listeners